When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Cocaine use disorder

Last reviewed: 20 Aug 2025
Last updated: 22 May 2025

Summary

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • hypertension
  • tachycardia
  • chest pain
  • mydriasis
  • diaphoresis
  • tremulousness
  • agitation (mild to severe)
  • mood changes (e.g., irritability, euphoria, dysphoria, paranoia)
  • suicide ideation
Todos los datos

Otros factores de diagnóstico

  • anxiety (panic state: mild to severe)
  • drug-induced formication
  • previous hospitalisation for medically supervised withdrawal
  • heat-related injuries (e.g., blisters, sores, and cuts on the mouth) or burns on the thumbs
  • nasal septum ulceration, perforation
  • focal neurological abnormalities
  • seizure activity
  • loss of consciousness/altered consciousness
  • skin lesions (e.g., puncture marks, infections, erosions, necrosis)
  • dyspnoea
Todos los datos

Factores de riesgo

  • adverse childhood events
  • history of polysubstance use
  • family history of substance use disorders
  • history of mental health disorder
  • male sex
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • urine toxicology ± gas chromatography/mass spectrometry testing
  • ECG
  • cardiac enzymes
Todos los datos

Pruebas diagnósticas que deben considerarse

  • chest x-ray
  • CT head
  • electroencephalogram
  • comprehensive blood panel
  • hepatitis serology
  • HIV serology
Todos los datos

Algoritmo de tratamiento

Agudo

acute intoxication

non-pregnant adults and adolescents: mild cocaine use disorder

non-pregnant adults and adolescents: moderate to severe cocaine use disorder

pregnant

En curso

sustained remission

treatment resistant

Colaboradores

Autores

Kim Wolff, MBE, PhD

Professor of Analytical, Forensic, and Addiction Science, Director, King’s Forensics

Faculty Life Science and Medicine

King’s College London

London

UK

Divulgaciones

KW declares that she has no competing interests.

Agradecimientos

Professor Kim Wolff would like to gratefully acknowledge Dr Steven B. Karch, the previous contributor to this topic.

Divulgaciones

SBK is an author of a number of references cited in this topic. SBK gives expert testimony and receives royalties from a textbook that he authored.

Revisores por pares

Andrew J. Saxon, MD

Professor

Department of Psychiatry and Behavioral Sciences

University of Washington School of Medicine

Seattle

WA

Divulgaciones

AS declares that he receives royalties from UpToDate, Inc.

Adam Bisaga, MD

Professor

Clinical Psychiatry

Columbia University College of Physicians and Surgeons

New York City

NY

Divulgaciones

AB declares that his research team and institution received funding and medication donations from Alkermes.

Christos Kouimtsidis, MBBS, MSc, MRCPsych, PhD

Consultant Psychiatrist and Honorary Senior Lecturer

Addictions, Alcohol Research

Institute of Psychiatry

King's College London

London

UK

Divulgaciones

CK declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

Clinical Guideline Committee (CGC) Members, ASAM Team, AAAP Team, et al. The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder. J Addict Med. 2024 May-Jun 01;18(1s suppl 1):1-56.Texto completo  Resumen

Department of Health and Social Care. Drug misuse and dependence: UK guidelines on clinical management. Dec 2017 [internet publication].Texto completo

World Health Organization. Guidelines for identification and management of substance use and substance use disorders in pregnancy. Nov 2014 [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Thyrotoxicosis
    • Amfetamine and methamphetamine use disorder
    • Mood disorder
    Más Diferenciales
  • Guías de práctica clínica

    • Engagement and retention of nonabstinent patients in substance use treatment
    • The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder
    Más Guías de práctica clínica
  • Folletos para el paciente

    Cocaine use disorder

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad